Ensuring patient access to gene therapies for rare diseases: Navigating reimbursement and coverage challenges
The rapid transformation in rare disease treatment, driven by advances in genetic medicine and diagnostics, underscores the urgent need for access to these innovative therapies. With over 10,000 identified rare diseases globally, 80% of which are genetic, the current therapeutic landscape indicates...
Saved in:
Main Authors: | Diane Berry, Carolyn Hickey, Lisa Kahlman, James Long, Christina Markus, Caitlin K. McCombs |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050124002195 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiparametric optimization of coverage for access network
by: Vitas Grimaila, et al.
Published: (2004-12-01) -
Winner’s Optimal Reimbursement in Contest
by: Yong Liu, et al.
Published: (2019-01-01) -
Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review
by: Zheng Zhu, et al.
Published: (2025-02-01) -
Ensuring access to palliative care for cervical cancer patients
by: F Ooko
Published: (2023-12-01) -
Court costs as an element of the mechanism of ensuring access to justice
by: M. V. Haidar, et al.
Published: (2024-12-01)